Toronto, Ontario–(Newsfile Corp. – November 6, 2026) – Vimy Pharmaceuticals Inc. (“Vimy Pharma” or the “Company”) and Harmony Acquisitions Corp. (TSXV: MONY.P) (“Harmony”) are pleased to jointly announce that they have received conditional approval from the TSX Venture Exchange (the “TSXV”) for Harmony’s previously announced “Qualifying Transaction” (as such term is defined in TSXV Policy 2.4 – Capital Pool Companies). The proposed business combination transaction (the “Transaction”) will be…
